Cubist Systematic Strategies, LLC Dynavax Technologies Corp Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$13.09 - $14.98 $117,090 - $133,996	8,945 New	8,945 $125,000
Q4 2022 Feb 14, 2023	SELL	$10.27 - $13.29 $1.17 Million - $1.51 Million	-113,568 Reduced 55.53%	90,947 $967,000
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $876,838 - $1.54 Million	88,302 Added 75.98%	204,515 $2.14 Million
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $187,285 - $322,533	25,139 Added 27.6%	116,213 $1.46 Million
Q1 2022 May 16, 2022	SELL	$9.75 - $14.44 $1.58 Million - $2.34 Million	-162,333 Reduced 64.06%	91,074 $987,000
Q4 2021 Feb 14, 2022	BUY	$13.17 - $20.94 $1.76 Million - $2.79 Million	133,417 Added 111.19%	253,407 $3.57 Million
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $804,165 - $1.74 Million	87,791 Added 272.65%	119,990 $2.31 Million
Q2 2021 Aug 16, 2021	SELL	$7.25 - $10.99 $155,570 - $235,823	-21,458 Reduced 39.99%	32,199 $317,000
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $245,212 - $599,885	53,657 New	53,657 $527,000
Q4 2020 Feb 16, 2021	SELL	$3.73 - $5.6 $481,934 - $723,548	-129,205 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.32 - $11.7 $558,165 - $1.51 Million	129,205 New	129,205 $558,000
Q1 2020 May 15, 2020	SELL	$2.27 - $6.2 $179,552 - $490,407	-79,098 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.46 - $6.93 $235,940 - $472,563	68,191 Added 625.2%	79,098 $452,000
Q3 2019 Nov 14, 2019	SELL	$2.69 - $4.85 $136,323 - $245,788	-50,678 Reduced 82.29%	10,907 $39,000
Q2 2019 Aug 14, 2019	BUY	$3.65 - $7.89 $74,737 - $161,555	20,476 Added 49.81%	61,585 $246,000
Q1 2019 May 15, 2019	BUY	$7.08 - $12.09 $116,218 - $198,457	16,415 Added 66.47%	41,109 $301,000
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $79,609 - $129,878	9,780 Added 65.58%	24,694 $226,000
Q3 2018 Nov 14, 2018	BUY	$11.85 - $16.0 $172,701 - $233,184	14,574 Added 4286.47%	14,914 $185,000
Q2 2018 Aug 14, 2018	SELL	$15.15 - $20.75 $76,962 - $105,410	-5,080 Reduced 93.73%	340 $5,000
Q1 2018 May 15, 2018	BUY	$14.65 - $19.9 $31,131 - $42,287	2,125 Added 64.49%	5,420 $108,000
Q4 2017 Feb 14, 2018	SELL	$17.3 - $24.08 $36,485 - $50,784	-2,109 Reduced 39.03%	3,295 $62,000
Q3 2017 Nov 14, 2017	BUY	$15.2 - $21.5 $82,140 - $116,186	5,404	5,404 $116,000

Others Institutions Holding DVAX

# of Institutions

276

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

Black Rock Inc. New York, NY

21.9M
Shares

$277 Million
0.01% of portfolio
Deep Track Capital, LP Greenwich, CT

12.5M
Shares

$159 Million
5.15% of portfolio
Vanguard Group Inc Valley Forge, PA

9.22M
Shares

$117 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

8.33M
Shares

$105 Million
7.62% of portfolio
State Street Corp Boston, MA

7.69M
Shares

$97.4 Million
0.0% of portfolio

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.6B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account